Patents by Inventor Wendy Davis

Wendy Davis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for Identifying an Agent for Treating Abnormal Kidney Function
    Publication number: 20190107546
    Abstract: Biomarkers for pre-Diabetes, Diabetes and/or a Diabetes related conditions, and methods of their use, including the biomarkers in Tables 1 and 2 such as peroxiredoxin-2, complement C1q subcomponent subunit B, sulfhydryl oxidase 1 and apolipoprotein A-IV.
    Type: Application
    Filed: December 13, 2018
    Publication date: April 11, 2019
    Inventors: Thomas Stoll, Scott Bringans, Kaye Winfield, Tammy Casey, Wendy Davis, Kirsten Peters, Timothy Davis, Richard Lipscombe
  • Method for identifying an agent for treating abnormal kidney function
    Patent number: 10191067
    Abstract: Biomarkers for pre-Diabetes, Diabetes and/or a Diabetes related conditions, and methods of their use, including the biomarkers in Tables 1 and 2 such as peroxiredoxin-2, complement C1q subcomponent subunit B, sulfhydryl oxidase 1 and apolipoprotein A-IV.
    Type: Grant
    Filed: June 26, 2017
    Date of Patent: January 29, 2019
    Assignee: Proteomics International Pty Ltd
    Inventors: Thomas Stoll, Scott Bringans, Kaye Winfield, Tammy Casey, Wendy Davis, Kirsten Peters, Timothy Davis, Richard Lipscombe
  • Use of CD5 Antigen-Like as a Biomarker for Diabetic Nephropathy
    Publication number: 20170299613
    Abstract: Biomarkers for pre-Diabetes, Diabetes and/or a Diabetes related conditions, and methods of their use, including the biomarkers in Tables 1 and 2 such as peroxiredoxin-2, complement C1q subcomponent subunit B, sulfhydryl oxidase 1 and apolipoprotein A-IV.
    Type: Application
    Filed: June 26, 2017
    Publication date: October 19, 2017
    Inventors: Thomas Stoll, Scott Bringans, Kaye Winfield, Tammy Casey, Wendy Davis, Kirsten Peters, Timothy Davis, Richard Lipscombe
  • Method of assessing a subject for abnormal kidney function
    Patent number: 9733259
    Abstract: Biomarkers for abnormal kidney function, including the biomarkers in Tables 1 and 2 such as peroxiredoxin-2, complement C1q subcomponent subunit B, sulfhydryl oxidase 1 and apolipoprotein A-IV, and methods for their use in assessing abnormal kidney function are disclosed herein.
    Type: Grant
    Filed: August 24, 2015
    Date of Patent: August 15, 2017
    Assignees: Proteomics International Pty Ltd, The University of Western Australia
    Inventors: Thomas Stoll, Scott Bringans, Kaye Winfield, Tammy Casey, Wendy Davis, Kirsten Peters, Timothy Davis, Richard Lipscombe
  • Use of CD5 Antigen-Like as a Biomarker for Diabetic Nephropathy
    Publication number: 20150355198
    Abstract: Biomarkers for pre-Diabetes, Diabetes and/or a Diabetes related conditions, and methods of their use, including the biomarkers in Tables 1 and 2 such as peroxiredoxin-2, complement C1q subcomponent subunit B, sulfhydryl oxidase 1 and apolipoprotein A-IV.
    Type: Application
    Filed: August 24, 2015
    Publication date: December 10, 2015
    Inventors: Thomas Stoll, Scott Bringans, Kaye Winfield, Tammy Casey, Wendy Davis, Kirsten Peters, Timothy Davis, Richard Lipscombe
  • Method of assessing diabetic nephropathy using CD5 antigen-like
    Patent number: 9146243
    Abstract: Biomarkers for pre-Diabetes, Diabetes and/or a Diabetes related conditions, and methods of their use, including the biomarkers in Tables 1 and 2 such as peroxiredoxin-2, complement C1q subcomponent subunit B, sulfhydryl oxidase 1 and apolipoprotein A-IV.
    Type: Grant
    Filed: May 14, 2014
    Date of Patent: September 29, 2015
    Assignees: Proteomics International Pty Ltd, The University of Western Australia
    Inventors: Thomas Stoll, Scott Bringans, Kaye Winfield, Tammy Casey, Wendy Davis, Kirsten Peters, Timothy Davis, Richard Lipscombe
  • USE OF CD5 ANTIGEN-LIKE AS A BIOMARKER FOR DIABETIC NEPHROPATHY
    Publication number: 20140249049
    Abstract: Biomarkers for pre-Diabetes, Diabetes and/or a Diabetes related conditions, and methods of their use, including the biomarkers in Tables 1 and 2 such as peroxiredoxin-2, complement C1q subcomponent subunit B, sulfhydryl oxidase 1 and apolipoprotein A-IV.
    Type: Application
    Filed: May 14, 2014
    Publication date: September 4, 2014
    Applicants: PROTEOMICS INTERNATIONAL PTY LTD, THE UNIVERSITY OF WESTERN AUSTRALIA
    Inventors: Thomas STOLL, Scott BRINGANS, Kaye WINFIELD, Tammy CASEY, Wendy DAVIS, Kirsten PETERS, Timothy DAVIS, Richard LIPSCOMBE
  • BIOMARKERS ASSOCIATED WITH PRE-DIABETES, DIABETES AND DIABETES RELATED CONDITIONS
    Publication number: 20130177544
    Abstract: Biomarkers for pre-Diabetes, Diabetes and/or a Diabetes related conditions, and methods of their use, including the biomarkers in Tables 1 and 2 such as peroxiredoxin-2, complement C1q subcomponent subunit B, sulfhydryl oxidase 1 and apolipoprotein A-IV.
    Type: Application
    Filed: September 20, 2011
    Publication date: July 11, 2013
    Applicants: THE UNIVERSITY OF WESTERN AUSTRALIA, PROTEOMICS INTERNATIONAL PTY LTD
    Inventors: Thomas Stoll, Scott Bringans, Kaye Winfield, Tammy Casey, Wendy Davis, Kirsten Peters, Timothy Davis, Richard Lipscombe